Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?
β Scribed by Leonieke M.M. Wolters; Hubert G.M. Niesters; Robert A. de Man; Solko W. Schalm
- Book ID
- 114145215
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 167 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0166-3542
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The outcome of patients with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) referred for liver transplantation (LT) is unknown. A high frequency of lamivudine-resistant (LAM-R) HBV infection may increase the risk of liver-related death pre-transplantation and prophylaxis failure post
A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combinati